Shuttle Pharmaceuticals Holdings (SHPH) Other Non-Current Liabilities (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Other Non-Current Liabilities of $23423.0 in Q1 2026, down 76.5% quarter-over-quarter from $99687.0 in Q4 2025, and down 76.58% on a YoY basis from $100000.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $23423.0 for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities fell 76.58% year-over-year to $23423.0; the TTM figure through Mar 2026 stood at $23423.0 (down 76.58% YoY), while the FY2025 annual figure was $99687.0, down 85.95% from the prior year.
- Other Non-Current Liabilities was $23423.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $99687.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.4 million in Q1 2023 to a low of $8538.0 in Q3 2025.
- Historically, Other Non-Current Liabilities has averaged $374907.8 across 4 years, with a median of $214615.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 71.16% in 2024, then plunged 96.95% in 2025.
- A 4-year view of Other Non-Current Liabilities shows it stood at $414512.0 in 2023, then jumped by 71.16% to $709486.0 in 2024, then plunged by 85.95% to $99687.0 in 2025, then sank by 76.5% to $23423.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $23423.0 (Q1 2026), $99687.0 (Q4 2025), and $8538.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,423.00 |
| Dec 31, 2025 | 99,687.00 |
| Sep 30, 2025 | 8,538.00 |
| Jun 30, 2025 | 10,965.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 709,486.00 |
| Sep 30, 2024 | 74,107.00 |
| Jun 30, 2024 | 359,919.00 |
| Mar 31, 2024 | 214,615.00 |
| Dec 31, 2023 | 414,512.00 |
| Sep 30, 2023 | 512,825.00 |
| Jun 30, 2023 | 955,725.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2021 | 334,955.00 |